The Parkinsons Institute

Sunnyvale, California 94089

0 studies enrolling now · 20 studies all time

What they study most

Dopamine Beta Hydroxylase Deficiency, Essential Tremor, Movement Disorders, Multiple System Atrophy, Neurogenic Orthostatic Hypotension, Non-Diabetic Autonomic Neuropathy, Non-diabetic Neuropathy, Parkinson Disease, Parkinson's Disease, Parkinson's Disease With Cognitive Impairments, Primary Autonomic Failure, REM Sleep Behavior Disorder

Studies at this site

• Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression — Completed
• Cala ONE Device for Essential Tremor — Completed
• Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia — Completed
• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease — Completed
• Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study — Completed
• A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease — Completed
• Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease — Status unconfirmed
• Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists — Completed
• Farming and Movement Evaluation Study (FAME) — Completed
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
• A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients — Status unconfirmed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease — Completed
• Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) — Completed
• Understanding the Natural History of REM Sleep Behavior Disorder — Status unconfirmed
• Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease — Stopped early
• Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy — Completed
• A Longitudinal Observational Follow-up of the PRECEPT Study Cohort — Status unconfirmed
• POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease — Completed